Introduction {#s0001}
============

The African penguin (*Spheniscus demersus*) is considered an endangered species (BirdLife International [@CIT0006]) that breeds from central Namibia to South Africa's Eastern Cape Province (Hockey, Dean & Ryan [@CIT0032]) ([Figure 1](#F0001){ref-type="fig"}). There has been more than a 60% decrease in the population between 2001 and 2009, mainly attributable to changes in overall abundance and local availability of prey (Crawford *et al*. [@CIT0012], [@CIT0013]; Sherley *et al*. [@CIT0055]). The levels of breeding success were deemed inadequate to sustain the African penguin population, and among other conservation efforts, limiting mortality through controlling the spread of disease was suggested to try to maintain an equilibrium situation (Crawford *et al*. [@CIT0012]).

![The natural distribution of the African penguin (light grey area) showing the sample collection sites (black dots).](OJVR-83-1147-g001){#F0001}

Disease is a major ecological force that has the potential to cause significant effects especially in threatened populations (Friend, McLean & Dein [@CIT0020]) and Heard *et al*. ([@CIT0031]) showed that the threat of disease increases with the level of extinction risk in all species. However, there is limited knowledge on the effects of disease on population dynamics of seabirds (Lewison *et al*. [@CIT0041]) or even for the role of disease as a major threat to species at risk of extinction (Heard *et al*. [@CIT0031]). While a single disease outbreak could decimate a population, the true cost of disease may be associated with chronic attrition of the population (Friend *et al*. [@CIT0020]) and thereby influence metabolic rate, life history traits and social status (Barbosa & Palacios [@CIT0005]).

Comprehensive health assessments of free-ranging avian species have rarely been reported in the literature (Smith *et al*. [@CIT0056]). Modern conservation efforts can be enhanced by the availability of comprehensive health assessment data at a population level (Karesh & Cook [@CIT0037]). Disease is often listed as a predicted threat to threatened species but this is generally a precautionary approach because there is a lack of surveillance data necessary to fully evaluate the threat (Heard *et al*. [@CIT0031]). Therefore, health assessments and the compilation of baseline data on the presence of parasites and potential pathogens fill a critical data gap, particularly for endangered species. If a species is negatively affected by a major threat other than disease, that species is more likely to be simultaneously threatened by disease (Heard *et al*. [@CIT0031]).

Several parasites have been recorded from the African penguin: seven trematode species, two nematode species, one argasidae tick species and two louse species (Brandão, Moreira & Luque [@CIT0008]). Only the trematode *Cardiocephaloides physalis* has caused mortality in the African penguin (Randall & Bray [@CIT0054]; Horne, Bray & Bousfield [@CIT0033]); however, all parasite species may affect the fitness of the host, predispose the individual to disease, cause poor breeding productivity and nest desertion (Brandão *et al*. [@CIT0008]; Duffy [@CIT0017]; Kanarek, Horne & Zaleśny [@CIT0036]).

A large-scale health assessment was conducted on the African penguin following the methods reported by Karesh *et al*. ([@CIT0038]), Smith *et al*. ([@CIT0056]) and Travis *et al*. ([@CIT0059]) on other penguin species, using blood smear examination, haematology, biochemistry and serology. Adult penguins in the breeding season on the colonies in South Africa as well as penguins admitted for rehabilitation were sampled. Additional samples included banked serum samples from penguins previously admitted to the Southern African Foundation for the Conservation of Coastal Birds (SANCCOB) and previous colony samples.

Methods {#s0002}
=======

Sampling procedures {#s20003}
-------------------

A total of 578 samples from the breeding range were analysed in this study. These samples were obtained from African penguins bled at Western Cape and Eastern Cape breeding colonies as well as from African penguins bled on admission for rehabilitation to SANCCOB (Cape Town, Western Cape); collected from various Namibian colonies in 2009 and from areas in the Western Cape from 2010 to 2013 ([Figure 1](#F0001){ref-type="fig"}). African penguins are admitted for rehabilitation because of oiling, debilitation, injuries, arrested moult and eggs and chicks admitted for hand-rearing (Parsons & Underhill [@CIT0052]). [Table 1](#T0001){ref-type="table"} summarises the distribution of the sampling effort in relation to the sample collection site, month and year, clinical history and laboratory examinations.

###### 

Summary of the sampling effort and tests evaluated during this health assessment of African penguins.

  Group                       Location            Sampling period   Clinical history   Sample size   Blood smear   Haematology   Serum chemistry   Serology   Sexing
  --------------------------- ------------------- ----------------- ------------------ ------------- ------------- ------------- ----------------- ---------- --------
  Western Cape 2007--2008     Dassen Island       December 2007     Healthy            38            \-            \-            \-                X          \-
                              Dassen Island       December 2008     Healthy            41            \-            \-            \-                X          \-
                              Robben Island       December 2007     Healthy            17            \-            \-            \-                X          \-
                              Robben Island       December 2008     Healthy            38            \-            \-            \-                X          \-
                              Boulders            February 2008     Healthy            10            \-            \-            \-                X          \-
                              Dyer Island         January 2008      Healthy            23            \-            \-            \-                X          \-
                              Dyer Island         December 2008     Healthy            38            \-            \-            \-                X          \-
  Namibia 2009                Halifax Island      April 2009        Oiled              9             X             \-            \-                X          X
                              Ichaboe Island      April 2009        Oiled              12            X             \-            \-                X          X
                              Mercury Island      April 2009        Oiled              15            X             \-            \-                X          X
                              Possession Island   April 2009        Oiled              5             X             \-            \-                X          X
  Western Cape 2010--2012     Dassen Island       December 2011     Healthy            20            X             X             X                 X          X
                              Robben Island       June 2011         Healthy            20            X             X             X                 X          X
                              Boulders            August 2012       Healthy            20            X             X             X                 X          X
                              Betty's Bay         August 2010       Healthy            20            X             X             X                 X          X
                              Dyer Island         August 2010       Healthy            20            X             X             X                 X          X
  Eastern Cape 2012           Bird Island         July 2012         Healthy            50            X             X             X                 X          X
                              St. Croix Island    July 2012         Healthy            17            X             X             X                 X          X
  Rehabilitation 2010--2013   SANCCOB             2010--2013        Oiled              60            X             X             X                 X          X
                              SANCCOB             2010--2013        Chick              53            X             X             X                 X          X
                              SANCCOB             2010--2013        Moulting           17            X             X             X                 X          X
                              SANCCOB             2010--2013        Weak or wounded    35            X             X             X                 X          X

SANCCOB, Southern African Foundation for the Conservation of Coastal Birds.

Colony samples were collected from penguins that were visually healthy on examination by a veterinarian. All penguins sampled at breeding colonies were adults, with the exception of 11 chicks and 1 juvenile sampled in the Western Cape 2007--2008 group. Birds selected were either resting in the colony or sitting on nests with medium to large chicks. Handling time was 5--10 min per bird, and the birds were released near their nest sites. Samples collected from penguins in the Namibia 2009 group were obtained on the second day of admission to the centre, and all were adults. Samples collected from penguins in the rehabilitation 2010--2013 group were obtained within the first 3 days of admission to the centre and comprised 53 chicks, 25 juveniles and 87 adults. For 365 of the total samples, sex was determined through routine DNA analysis by Molecular Diagnostic Services (Pty) Ltd (Durban, South Africa): 186 male penguins (51%) and 179 female penguins (49%).

Haematology {#s20004}
-----------

Blood (5 mL -- 20 mL) was collected through veni-puncture of the jugular vein using a 21-G needle (25 mm × 0.8 mm), immediately transferred into ethylenediaminetetraaceticacid and serum clot activator tubes (Vacuette^®^; Greiner Bio-One, Austria) and stored at 4 °C for up to 60 h until being analysed. Serum clot activator tubes were centrifuged and serum transferred into separate eppendorf tubes and immediately frozen at -20 °C. Blood smears were prepared, air-dried, fixed in methanol and stained with modified Wright--Giemsa stain (Kyro-Quick^®^; Kyron Laboratories \[Pty\] Ltd, Benrose, South Africa). All slides were examined for blood parasites for 10 min using a 50× oil immersion lens with a 10× eyepiece. Haematology and biochemistry analyses were performed following routine laboratory procedures at IDEXX Laboratories (Pty) Ltd (Cape Town, South Africa) (see Parsons *et al*. [@CIT0051] for details).

Serology {#s20005}
--------

The frozen serum samples were submitted to the Western Cape Provincial Veterinary Laboratory (Stellenbosch, South Africa) for haemagglutination inhibition assay (HIA) for avian influenza virus subtypes H5 and H7 (AIV H5, AIV H7) and Newcastle disease virus (NDV) and for serum plate agglutination (SPA) testing for *Mycoplasma gallisepticum* (MG) and *Mycoplasma synoviae* (MS). The HIA testing for avian influenza virus was done according to the protocol for non-chicken species (World Organisation for Animal Health [@CIT0067]). Additionally, samples were submitted to IDEXX Laboratories (Pty) Ltd (Johannesburg, South Africa) for indirect enzyme-linked immunosorbent assay (ELISA) testing for avian infectious bronchitis virus (IBV), avian encephalomyelitis virus (AEV), avian reovirus (ARV), infectious bursal disease virus (IBDV), MG and MS ([Table 2](#T0002){ref-type="table"}). ELISA testing used secondary antibodies targeting chicken IgY. In the case of *Mycoplasma* spp., SPA and ELISA were used to test different subsets of samples. Because of the occurrence of herpesvirus respiratory infections at the same facility (Parsons *et al*. [@CIT0050]), a limited number of samples were submitted to Agrilabs (Pioneerfoods \[Pty\] Ltd, Malmesbury, South Africa) to be tested for infectious laryngotracheitis virus (ILTV, also referred to as gallid herpesvirus 1) through indirect ELISA.

###### 

Diagnostic results for pathogens tested during this health assessment of African penguins.

  Pathogen                             Test          Western Cape 2007--2008   Western Cape 2010--2012   Eastern Cape 2012   Namibia spill 2009   Rehabilitation 2010--2013   Total                                                                   
  ------------------------------------ ------------- ------------------------- ------------------------- ------------------- -------------------- --------------------------- ------------ ------------ ------------ ---------- --------- ----------- ---------
  **Serology**                                                                                                                                                                                                                                        
  Avian encephalomyelitis virus        ELISA         0.93                      107                       5.00                100                  0.00                        65           10.00        20           3.31       151       2.93        443
  Avian infectious bronchitis virus    ELISA         6.54                      107                       0.00                100                  0.00                        65           40.00        20           0.66       151       3.61        443
  Avian Influenza Virus subtype H5     HIA           0.00                      98                        0.00                100                  0.00                        67           0.00         21           0.00       153       0.00        439
  Avian Influenza Virus subtype H7     HIA           0.00                      98                        0.00                100                  0.00                        67           0.00         21           0.00       153       0.00        439
  Avian reovirus                       ELISA         2.80                      107                       0.00                100                  0.00                        65           5.00         20           0.00       151       0.90        443
  Infectious bursal disease virus      ELISA         4.67                      107                       2.00                100                  0.00                        65           15.00        20           1.32       151       2.71        443
  Infectious laryngotracheitis virus   ELISA         Not tested                Not tested                0.00                37                   Not tested                  Not tested   Not tested   Not tested   0.00       36        0.00        73
  Newcastle Disease Virus              HIA           2.04                      98                        3.00                100                  0.00                        67           0.00         21           0.00       153       1.14        439
  *Mycoplasma gallisepticum*           SPA           5.26                      95                        22.64               53                   Not tested                  Not tested   0.00         21           3.08       65        8.12        234
  *Mycoplasma gallisepticum*           ELISA         Not tested                Not tested                2.50                40                   0.00                        65           Not tested   Not tested   0.00       84        0.53        189
  *Mycoplasma synoviae*                SPA           9.47                      95                        1.72                58                   Not tested                  Not tested   0.00         21           0.00       65        4.18        239
  *Mycoplasma synoviae*                ELISA         Not tested                Not tested                2.50                40                   0.00                        65           Not tested   Not tested   0.00       84        0.53        189
  **Total**                                          **20.00**                 **205**                   **25.00**           **100**              **0.00**                    **67**       **34.15**    **41**       **6.06**   **165**   **11.76**   **578**
  **Blood smear examination**                                                                                                                                                                                                                         
  *Babesia* sp.                        Blood smear   Not tested                Not tested                3.00                100                  1.52                        66           2.44         41           17.68      164       9.16        371
  *Borrelia* sp.                       Blood smear   Not tested                Not tested                0.00                100                  0.00                        66           0.00         41           1.83       164       0.81        371

SPA, serum plate agglutination; HIA, haemagglutination inhibition assay; ELISA, enzyme-linked immunosorbent assay.

Data analysis {#s20006}
-------------

Statistical significance was set at 0.05 and tests were two-tailed using SPSS 21 for Windows (IBM Corp., 2011, Armonk, NY, USA). Fisher's exact test was used to evaluate if the seroprevalence (number of positive samples/number of samples tested) for *Mycoplasma* spp. was different in relation to the serological test (SPA or ELISA). The data set presented by Parsons *et al*. ([@CIT0051]) was used as haematological reference values for comparison with seropositive individuals; this data set comprises the seronegative and blood parasite-negative, apparently healthy adult African penguins sampled at colonies in this study. Mann-Whitney tests were used to compare haematological results between reference values and individuals that were seropositive for AEV, MG (SPA test) or two or more pathogens. Haematological results of individuals seropositive for other pathogens were not included in this analysis because of insufficient sample size (less than five samples).

Because *c.* 60% of the blood parasite-positive individuals were chicks, a different data set had to be used as reference values to evaluate the haematological results of these individuals; seronegative and blood parasite-negative apparently healthy African penguin chicks admitted to SANCCOB were used as a reference data set. Mann--Whitney tests were used to compare haematological results between these reference values and individuals positive for *Babesia* sp. On the other hand, *Borrelia* sp.--positive and mixed infection--positive individuals were not included in this analysis because of insufficient sample size.

Results {#s0007}
=======

A total of 578 individuals were screened; of those, 68 penguins were seropositive for at least one of the nine pathogens tested ([Table 2](#T0002){ref-type="table"}); of these, 12 individuals were seropositive for more than one of the diseases tested: AEV + IBDV (2 samples), AEV + IBV (1), AEV + IBDV + IBV (1), AEV + MG (1), ARV + IBV (1), IBDV + IBV (2), IBDV + MS (1), MG + MS (2), and MG + NDV (1). All samples were seronegative for AIV H5, AIV H7 and ILTV. Samples tested for antibodies against *Mycoplasma* spp. using SPA were more frequently positive (4.2% for MG and 8.1% for MS) than those tested using ELISA (0.5% for both MG and MS); this occurred for both MG (*p* \< 0.01) and MS (*p* = 0.03). Haematological results for seropositive individuals are presented in [Table 3](#T0003){ref-type="table"}.

###### 

Morphometry, haematology and serum chemistry results of seropositive individuals, in relation to reference values for healthy adult wild African penguins.

  Parameter                Unit       Reference values (healthy adults)   Avian encephalomyelitis virus   *Mycoplasma gallisepticum* (serum plate agglutination test)   Two or more pathogens                  Infectious bursal disease virus   Infectious bronchitis virus             Newcastle disease virus                                                                                                                             
  ------------------------ ---------- ----------------------------------- ------------------------------- ------------------------------------------------------------- -------------------------------------- --------------------------------- --------------------------------------- ------------------------- -------------------------------------- ------- ------ ------------- -------------------------------------- ------- ------ ---
  Head length              mm         121.1 ± 3.9                         108                             120.0 ± 5.9                                                   7                                      120.1 ± 3.2                       12                                      118.4 ± 7.4               6                                      127.2   1      117.9         1                                      118.3   2      
  Body mass                kg         2.86 ± 0.37                         108                             2.62 ± 0.40                                                   8[\*](#TFN0001){ref-type="table-fn"}   2.76 ± 0.30                       12                                      2.71 ± 0.50               10                                     2.84    1      2.43 ± 0.10   5[\*](#TFN0001){ref-type="table-fn"}   2.62    2      
  Haematocrit              \%         46.0 ± 5.7                          107                             46.1 ± 4.6                                                    8                                      45.1 ± 3.3                        12                                      46.6 ± 7.9                10                                     38.0    1      50.6 ± 3.5    5                                      51.0    2      
  Haemoglobin              g/dL       18.4 ± 2.4                          103                             19.2 ± 0.6                                                    6                                      18.9 ± 1.8                        12                                      19.1 ± 1.6                5                                      16.1    1      19.3          1                                      19.3    2      
  Red blood cell count     10^12^/L   1.82 ± 0.26                         103                             1.94 ± 0.09                                                   6                                      1.83 ± 0.19                       12                                      1.93 ± 0.15               5                                      1.65    1      1.99          1                                      1.88    2      
  MCV                      fL         251.0 ± 35.6                        103                             243.1 ± 13.9                                                  6                                      248.5 ± 27.8                      12                                      246.3 ± 13.1              5                                      230.3   1      236.2         1                                      271.9   2      
  MCH                      pg         101.1 ± 14.3                        103                             99.0 ± 2.7                                                    6                                      104.0 ± 11.5                      12                                      98.8 ± 4.6                5                                      97.6    1      97.0          1                                      102.7   2      
  MCHC                     g/dL       40 ± 3.5                            103                             40.8 ± 1.5                                                    6                                      41.9 ± 1.9                        12                                      40.2 ± 2.1                5                                      42.4    1      41.1          1                                      37.8    2      
  White blood cell count   10^9^/L    17.7 ± 8.4                          103                             13.0 ± 8.1                                                    6                                      20.2 ± 4.5                        12                                      17.0 ± 3.7                5                                      30.0    1      14.2          1                                      22.4    2      
  Sodium                   mmol/L     154 ± 6                             105                             146 ± 9                                                       7[\*](#TFN0001){ref-type="table-fn"}   145 ± 5                           12[\*](#TFN0001){ref-type="table-fn"}   151 ± 5                   6                                      148     1      146           1                                      158     1      
  Potassium                mmol/L     5.09 ± 2.52                         105                             5.00 ± 1.48                                                   7                                      10.05 ± 4.39                      12[\*](#TFN0001){ref-type="table-fn"}   4.85 ± 1.12               6                                      6.20    1      5.86          1                                      3.65    1      
  Chloride                 mmol/L     121 ± 6                             104                             115 ± 7                                                       7[\*](#TFN0001){ref-type="table-fn"}   115 ± 5                           12[\*](#TFN0001){ref-type="table-fn"}   116 ± 4                   6[\*](#TFN0001){ref-type="table-fn"}   114     1      109           1                                      128     1      
  Calcium                  mmol/L     2.77 ± 0.82                         105                             2.53 ± 0.19                                                   7                                      2.43 ± 0.24                       12                                      2.50 ± 0.09               6                                      1.96    1      2.35          1                                      2.58    1      
  Inorganic phosphate      mmol/L     1.53 ± 0.62                         105                             1.35 ± 0.46                                                   7                                      1.65 ± 1.03                       12                                      1.48 ± 0.55               6                                      1.20    1      1.80          1                                      1.69    1      
  Creatinine               mmol/L     24.1 ± 11.9                         105                             20.0 ± 17.0                                                   7                                      12.6 ± 9.9                        12[\*](#TFN0001){ref-type="table-fn"}   16.8 ± 8.5                6[\*](#TFN0001){ref-type="table-fn"}   5.0     1      4.0           1                                      16.0    1      
  Cholesterol                         mmol/L                              5.36 ± 1.36                     105                                                           5.41 ± 1.20                            7                                 6.12 ± 1.37                             12                        5.32 ± 0.67                            6       5.70   1             4.30                                   1       6.10   1
  Glucose                  mmol/L     11.8 ± 2.2                          105                             12.5 ± 1.4                                                    7                                      12.6 ± 1.2                        12                                      12.2 ± 1.5                6                                      11.1    1      11.9          1                                      10.0    1      
  Uric Acid                mmol/L     394 ± 221                           104                             604 ± 482                                                     7                                      345 ± 280                         11                                      539 ± 186                 6                                      73      1      448           1                                      263     1      
  Bile Acids               mmol/L     9.53 ± 16.75                        87                              18.26 ± 15.33                                                 5                                      9.26 ± 13.30                      9                                       17.54 ± 21.15             5                                      1.64    1      7.20          1                                      23.56   2      
  Total serum protein      g/L        59.0 ± 9.6                          105                             53.7 ± 7.0                                                    7                                      70.0 ± 5.8                        12                                      61.8 ± 8.6                6                                      53.7    1      51.0          1                                      49.0    1      
  Albumin                  g/L        19.3 ± 4.0                          105                             16.6 ± 3.2                                                    7                                      21.0 ± 3.2                        12                                      20.5 ± 3.0                6                                      16.6    1      16.0          1                                      15.0    1      
  Globulin                 g/L        39.8 ± 6.3                          105                             37.1 ± 3.9                                                    7                                      49.0 ± 3.5                        12                                      41.3 ± 5.8                6                                      37.1    1      35.0          1                                      35.0    1      
  Albumin / globulin       \-         0.48 ± 0.05                         105                             0.44 ± 0.05                                                   7                                      0.50 ± 0.06                       12                                      0.46 ± 0.04               6                                      0.46    1      0.43          1                                      0.43    1      
  Aspartate transaminase   U/L        218 ± 90                            104                             293 ± 235                                                     7                                      247 ± 107                         12                                      184 ± 44                  6                                      151     1      326           1                                      120     1      
  Creatine kinase          U/L        419 ± 272                           105                             461 ± 498                                                     7                                      561 ± 358                         12                                      365 ± 187                 6                                      188     1      375           1                                      385     1      

*Source:* Reference values obtained from Parsons *et al*. ([@CIT0051]); all other values from this study

MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration.

indicate groups that were significantly different from the reference values (only evaluated when sample size was ≥ 5).

Blood smears revealed 33 samples were positive for *Babesia* sp., 2 individuals were positive for *Borrelia* sp. and 1 individual was positive for both *Babesia* sp. and *Borrelia* sp. ([Table 2](#T0002){ref-type="table"}); no other blood parasites were observed. These blood parasites were morphologically consistent with those documented by Earlé *et al*. ([@CIT0018]) and Yabsley *et al*. ([@CIT0068]). Only two blood smear--positive individuals (*Babesia*-positive) were also found to be seropositive: one was seropositive to MG (SPA test) and the other was seropositive to both AEV and IBDV. Haematological results for blood smear--positive individuals are presented in [Table 4](#T0004){ref-type="table"}.

###### 

Morphometry, haematology and serum chemistry results of blood smear--positive individuals, in relation to reference values for healthy African penguin chicks admitted to the Southern African Foundation for the Conservation of Coastal Birds (this study) and healthy adult wild African penguins.

  Parameter                Unit       Reference values   *Babesia* sp.   *Borrelia* sp.   Co-infection by *Babesia* sp. and *Borrelia* sp.                                                                                                                                      
  ------------------------ ---------- ------------------ --------------- ---------------- -------------------------------------------------- --------------- --------------------------------------- -------------- --------------------------------------- ------- --- ------- ---
  Head length              mm         106.7 ± 4.8        30              121.1 ± 3.9      108                                                103.9 ± 5.2     20[\*](#TFN0002){ref-type="table-fn"}   119.3 ± 4.3    12                                      104.1   2   99.3    1
  Body mass                kg         2.32 ± 0.30        30              2.86 ± 0.37      108                                                2.20 ± 0.20     20                                      2.36 ± 0.50    13[\*](#TFN0002){ref-type="table-fn"}   1.67    2   2.02    1
  Haematocrit              \%         31.7 ± 6.4         30              46.0 ± 5.7       107                                                29.3 ± 5.0      20                                      40.5 ± 10.7    13                                      35.5    2   25.0    1
  Haemoglobin              g/dL       12.6 ± 1.9         22              18.4 ± 2.4       103                                                9.3 ± 2.3       13[\*](#TFN0002){ref-type="table-fn"}   15.1 ± 5.4     11[\*](#TFN0002){ref-type="table-fn"}   12.2    1   8.2     1
  Red blood cell count     10^12^/L   1.53 ± 0.18        22              1.82 ± 0.26      103                                                1.15 ± 0.32     13[\*](#TFN0002){ref-type="table-fn"}   1.65 ± 0.37    11                                      1.61    1   1.00    1
  MCV                      fL         220.8 ± 14.7       22              251.0 ± 35.6     103                                                275.5 ± 41.6    13[\*](#TFN0002){ref-type="table-fn"}   235.0 ± 30.3   11                                      211.2   1   250.0   1
  MCH                      pg         81.8 ± 4.8         22              101.1 ± 14.3     103                                                81.5 ± 4.3      13                                      88.3 ± 19.3    11[\*](#TFN0002){ref-type="table-fn"}   75.8    1   82.0    1
  MCHC                     g/dL       37.2 ± 3.0         22              40.0 ± 3.5       103                                                30.1 ± 4.1      13[\*](#TFN0002){ref-type="table-fn"}   37.2 ± 5.3     11[\*](#TFN0002){ref-type="table-fn"}   35.9    1   32.8    1
  White blood cell count   10^9^/L    15.0 ± 5.2         22              17.7 ± 8.4       103                                                21.2 ± 5.0      13[\*](#TFN0002){ref-type="table-fn"}   31.4 ± 23.4    11[\*](#TFN0002){ref-type="table-fn"}   24.6    1   14.2    1
  Sodium                   mmol/L     146 ± 5            27              154 ± 6          105                                                148 ± 3         19[\*](#TFN0002){ref-type="table-fn"}   144 ± 13       11[\*](#TFN0002){ref-type="table-fn"}   140     2   139     1
  Potassium                mmol/L     5.45 ± 0.71        27              5.09 ± 2.52      105                                                5.67 ± 0.74     19                                      5.57 ± 1.59    9[\*](#TFN0002){ref-type="table-fn"}    4.91    2   5.03    1
  Chloride                 mmol/L     113 ± 5            27              121 ± 6          104                                                115 ± 3         19                                      112 ± 9        11[\*](#TFN0002){ref-type="table-fn"}   108     1   105     1
  Calcium                  mmol/L     2.58 ± 0.15        27              2.77 ± 0.82      105                                                2.57 ± 0.11     19                                      2.38 ± 0.35    11                                      2.53    2   2.34    1
  Inorganic phosphate      mmol/L     1.89 ± 0.28        26              1.53 ± 0.62      105                                                2.31 ± 0.49     19[\*](#TFN0002){ref-type="table-fn"}   2.08 ± 1.55    11                                      2.35    2   1.73    1
  Creatinine               mmol/L     17.6 ± 12.6        27              24.1 ± 11.9      105                                                20.6 ± 8.4      19                                      41.6 ± 44.8    11                                      41.5    2   22.0    1
  Cholesterol              mmol/L     4.45 ± 1.03        27              5.36 ± 1.36      105                                                4.61 ± 0.96     19                                      4.95 ± 2.13    11                                      5.00    2   2.70    1
  Glucose                  mmol/L     12.3 ± 1.3         27              11.8 ± 2.2       105                                                12.2 ± 1.0      19                                      10.4 ± 4.7     11                                      10.9    2   13.0    1
  Uric Acid                mmol/L     652 ± 319          27              394 ± 221        104                                                542 ± 436       18[\*](#TFN0002){ref-type="table-fn"}   562 ± 488      11                                      460     2   608     1
  Bile Acids               mmol/L     25.47 ± 14.25      22              9.53 ± 16.75     87                                                 14.19 ± 11.20   19                                      9.16 ± 13.37   11                                      43.10   2   12.39   1
  Total serum protein      g/L        43.1 ± 5.4         25              59.0 ± 9.6       105                                                46.3 ± 4.6      19[\*](#TFN0002){ref-type="table-fn"}   48.2 ± 17.7    11                                      45.5    2   34.0    1
  Albumin                  g/L        13.7 ± 1.4         27              19.3 ± 4.0       105                                                14.1 ± 1.6      19                                      15.5 ± 5.8     11[\*](#TFN0002){ref-type="table-fn"}   13.5    2   10.0    1
  Globulin                 g/L        29.6 ± 4.4         25              39.8 ± 6.3       105                                                31.8 ± 4.0      19                                      32.7 ± 12.3    11                                      32.0    2   24.0    1
  Albumin / globulin       \-         0.47 ± 0.05        25              0.48 ± 0.05      105                                                0.45 ± 0.04     19                                      0.49 ± 0.10    11                                      0.42    2   0.42    1
  Aspartate transaminase   U/L        145 ± 38           27              218 ± 90         104                                                151 ± 38        19                                      376 ± 247      11                                      797     2   120     1
  Creatine kinase          U/L        392 ± 124          27              419 ± 272        105                                                368 ± 153       19                                      1275 ± 2283    11[\*](#TFN0002){ref-type="table-fn"}   1559    2   250     1

*Source:* Reference values for adults obtained from Parsons *et al*. ([@CIT0051]), all other values from this study

MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration.

indicate groups that were significantly different from the reference values of their age class (only evaluated when the sample size was ≥ 5).

Of the positive individuals, 66 (97%) were adults compared to two (3%) chicks. There was no difference across genders. Of the positive adults, there were 49 (74%) that were sampled as healthy individuals in wild colonies (90% unknown breeding status, 10% sitting with chicks) and 17 (26%) sampled when admitted for rehabilitation (94% oiled, 6% injured). There was a significant difference in the prevalence of seropositive individuals between the three geographical areas: Namibia, Western Cape and Eastern Cape. Complete details on the sampling effort and serological and blood smear results in relation to age group and sex are provided in [Table 1-A1](#T0005){ref-type="table"}, and in relation to breeding colony in [Table 2-A1](#T0006){ref-type="table"}.

Ethical considerations {#s0008}
======================

Research permits to conduct this work were obtained by the Department of Environmental Affairs (DEA) (RES2012/61 EXT, RES2011/19, and RES2010/58), CapeNature (AAA007-00047-0056, AAA004-0508-0035, AAA004-000120-0035 and AAA007-00040-0035) and South African National Parks (PARSN1027). Procedures were approved by the Animal Ethics Committee of the DEA, and all blood samples were collected by veterinarians (N.J.P., T.A.G.) registered with the South African Veterinary Council. Where applicable, ARRIVE guidelines for reporting *in vivo* animal experiments (Kilkenny *et al*. [@CIT0039]) have been adhered to.

Discussion {#s0009}
==========

Our results should be interpreted taking into account the characteristics and inherent limitations of the serological tests used in this study. Because serological tests specifically designed for African penguins are not currently available, we used commercial tests designed for poultry. The indirect ELISA tests used in this study rely on the basic assumption that antibodies against chicken IgY can also reliably recognise penguin IgY. While these specific commercial tests have not undergone thorough validation to estimate their sensitivity and specificity when applied to samples from African penguins, other studies on the antigenic properties of penguin immunoglobulins corroborate the validity of their basic methodological assumption (Bizelli *et al*. [@CIT0007]; Graczyk *et al*. [@CIT0026], [@CIT0027]). Unfortunately, the lack of serological tests specifically designed or validated for penguins is a recurrent methodological limitation of serological inquiries in these species (Karesh *et al*. [@CIT0038]; Nunes *et al*. [@CIT0047]; Smith *et al*. [@CIT0056]; Travis *et al*. [@CIT0059]; Uhart *et al*. [@CIT0060]), which hopefully will be overcome through ongoing research aiming at the production of secondary antibodies specifically targeting penguin IgY (Bizelli *et al*. [@CIT0007]). On the other hand, the HIA used to test for NDV, AIV H5 and AIV H7 is not subject to this limitation because it does not rely on the recognition by secondary antibodies.

It is also worth noting that this is not a comprehensive study into all pathogens and parasites that can affect the health of African penguins on an individual or population level. Further studies looking at epidemiology as well as interaction between parasites, pathogens and fitness of individuals are encouraged.

Avian encephalomyelitis virus (Picornaviridae) {#s20010}
----------------------------------------------

Seropositivity to AEV was identified in the Namibian and the Western Cape samples and in penguins admitted for rehabilitation at SANCCOB; overall seroprevalence was relatively low (2.9%). AEV has been documented in domestic birds in South Africa (Odend'hal [@CIT0048]), but it has never been demonstrated to infect penguins by direct diagnostic methods. Serological surveys examining penguins in Peru and at the Falkland and Galapagos Islands have only found negative results (Smith *et al*. [@CIT0056]; Travis *et al*. [@CIT0059]; Uhart *et al*. [@CIT0060]), whereas Karesh *et al*. ([@CIT0038]) found antibodies against AEV in southern rockhopper penguins (*Eudyptes chrysocome*) in Argentina, with seroprevalence (3%) similar to that observed in this study.

AEV infections seldom cause clinical disease in adult chickens, but can lead to significant decreases in egg production and hatchability; however, in young chickens, AEV can produce paralysis, ataxia and muscular dystrophy (Tannock & Shafren [@CIT0057]). In this study, AEV seropositive penguins had slightly lower serum sodium and chloride concentrations; this cannot be explained by the pathogenesis of AEV infection and is therefore interpreted as an incidental finding.

Avian infectious bronchitis virus (Coronaviridae) {#s20011}
-------------------------------------------------

Seropositivity to IBV was identified in the Namibian and the Western Cape samples and in penguins admitted for rehabilitation at SANCCOB; overall seroprevalence was relatively low (3.6%). Few studies have tested penguins for antibodies against IBV. Karesh *et al*. ([@CIT0038]) found a seroprevalence between 23% and 47% (depending on the titre cutpoint) in southern rockhopper penguins in Argentina, whereas Smith *et al*. ([@CIT0056]) did not detect antibodies against this pathogen in Humboldt penguins (*Spheniscus humboldti*) in Peru. DNA from coronaviruses has been detected in the tissues of beachcast carcasses of Magellanic penguins (*Spheniscus magellanicus*) in Brazil; however, it is unclear whether these viruses were associated with disease (Niemeyer *et al*. [@CIT0046]).

Coronaviruses such as IBV are known to cause respiratory, intestinal and reproductive diseases in both domestic and wild birds (Gerlach [@CIT0023]). However, the significance of this infection in penguins is unclear. Individuals that were seropositive for IBV had significantly lower body mass but not head length than otherwise healthy adults, suggesting poorer body condition compared to those that were seronegative. However, this result should be interpreted with caution considering the low sample size.

Avian influenza virus (Orthomyxoviridae) {#s20012}
----------------------------------------

We found no serological evidence of highly pathogenic influenza A virus (subtypes H5 and H7), despite past evidence of their circulation in wild birds in South Africa (Abolnik *et al*. [@CIT0002]; Cumming *et al*. [@CIT0014]). Penguin seropositivity to AIV has been demonstrated by studies in the Antarctic (Abad *et al*. [@CIT0001]; Morgan & Westbury [@CIT0043]; Wallensten *et al*. [@CIT0063]) and Subantarctic (Abad *et al*. [@CIT0001]), and Hurt *et al*. ([@CIT0034]) have demonstrated that the AIV H11N2 present in penguins on the Antarctic Peninsula is an evolutionarily distinct lineage, not closely related to AIV strains from migratory flying birds. On the other hand, the few serological studies on penguins at lower latitudes conducted to date have failed to demonstrate exposure to AIV (Karesh *et al*. [@CIT0038]; Smith *et al*. [@CIT0056]; Travis *et al*. [@CIT0059]). However, this is unlikely to result from an absence of circulation of these viruses, as their worldwide distribution has been extensively documented (Olsen *et al*. [@CIT0049]). It is likely that these negative results reflect the fact that AIV occurrence is highly variable and species and location dependent (Hanson *et al*. [@CIT0029]). It must also be considered that antibodies against AIV subtypes other than H5 and H7 would have gone undetected by the tests used in this study.

Avian reovirus (Reoviridae) {#s20013}
---------------------------

Antibodies against ARV were detected in wild African penguins sampled in Namibia and the Western Cape, with a low overall seroprevalence (0.9%). Reovirus-like agents with some similarity to reference chicken reovirus strain were isolated in African penguins that died at a zoo in the United Kingdom (Gough *et al*. [@CIT0025]). However, in that case, the birds were seronegative to the one-way neutralisation test, and it was unclear what role the virus played in their deaths (Gough *et al*. [@CIT0025]). Surveys in Peru and on the Falkland and Galapagos Islands have found only seronegative penguins (Smith *et al*. [@CIT0056]; Travis *et al*. [@CIT0059]; Uhart *et al*. [@CIT0060]). On the other hand, Karesh *et al*. ([@CIT0038]) detected antibodies against ARV in 23% of southern rockhopper penguins sampled in Argentina. ARV has been documented in domestic birds worldwide, including South Africa, and may lead to a broad variety of clinical presentations (Gerlach [@CIT0023]; Van Loon *et al*. [@CIT0061]).

Infectious bursal disease virus (Birnaviridae) {#s20014}
----------------------------------------------

Antibodies against IBDV were detected in wild African penguins sampled in Namibia and the Western Cape and in penguins admitted for rehabilitation at SANCCOB; overall seroprevalence was relatively low (2.7%). Antibodies against IBDV have been demonstrated in penguins by studies using ELISA in Brazil (Nunes *et al*. [@CIT0047]) and virus neutralisation tests in Crozet Archipelago and at various locations in Antarctica (Gardner, Kerry & Riddle [@CIT0021]; Gauthier-Clerc *et al*. [@CIT0022]; Watts, Miller & Shellam [@CIT0064]), whereas studies using agar-gel diffusion tests have failed to obtain positive results in South America (Karesh *et al*. [@CIT0038]; Smith *et al*. [@CIT0056]; Travis *et al*. [@CIT0059]). Watts *et al*. ([@CIT0064]) argue that IBDV serotype 1 is endemic and widespread in Antarctic birds, with Emperor penguins (*Aptenodytes forsteri*) playing a key role in the virus' persistence in Antarctica.

IBDV is known to cause disease in young chickens, in which it can produce bursal lymphoid depletion and high mortality (World Organisation for Animal Health [@CIT0066]). No clinical signs of disease have been observed in any of the seropositive penguin species in the wild (Gardner *et al*. [@CIT0021]; Gauthier-Clerc *et al*. [@CIT0022]; Nunes *et al*. [@CIT0047]; Watts *et al*. [@CIT0064]). Gough *et al*. ([@CIT0025]) reported the isolation of IBDV serotype 2 from the tissues of African and Macaroni penguins (*Eudyptes chrysolophus*) deceased at a zoo in the United Kingdom and considered that although the infection was not primarily responsible for the deaths, it may have exacerbated concurrent disease conditions. Unfortunately, in this study, we did not have a sufficient number of seropositive penguins to evaluate the potential health effects of exposure to IBDV.

Infectious laryngotracheitis virus (Herpesviridae) {#s20015}
--------------------------------------------------

There were no positive samples in serology testing for ILTV (also known as gallid herpesvirus 1) despite previous evidence that African penguins are susceptible to herpesvirus-like infections (Kincaid, Bunton & Cranfield [@CIT0040]; Parsons *et al*. [@CIT0050]). Previous studies on other penguin species have also failed to identify antibodies against this virus (Karesh *et al*. [@CIT0038]; Smith *et al*. [@CIT0056]). Wild African penguin chicks have presented herpesvirus-like respiratory infections, which were not detected by molecular or serological tests targeting ILTV, suggesting that a different herpesvirus was involved (Parsons *et al*. [@CIT0050]).

Newcastle disease virus (Paramyxoviridae) {#s20016}
-----------------------------------------

Five individuals were seropositive to NDV (also known as avian paramyxovirus type 1), all of which were sampled in the Western Cape. Penguins that were seropositive for NDV have been demonstrated in the Antarctic (Morgan & Westbury [@CIT0043]), Argentina (Karesh *et al*. [@CIT0038]), Macquarie Island (Morgan *et al*. [@CIT0044]) and South Shetland Islands (Thomazelli *et al*. [@CIT0058]). Thomazelli *et al*. ([@CIT0058]) determined that the strains detected in penguins at the South Shetlands Islands had low pathogenicity. NDV infection has also been demonstrated in captive penguins in the United States (Pierson & Pfow [@CIT0053]), where a velogenic neurotropic strain was identified, and in Israel (Haddas *et al*. [@CIT0028]), where the pathogenicity of the strain could not be determined. It is clear that penguins are susceptible to this virus and that some NDV strains, presumably those with low pathogenicity, circulate in wild penguin populations. NDV has also been demonstrated in great white pelicans (*Pelecanus onocrotalus*) in the Western Cape (Assunção *et al*. [@CIT0003]).

It is interesting to note that one of the individuals identified as seropositive was a penguin that had been rehabilitated at SANCCOB 7 years earlier and, at that time, received vaccination for NDV. The vaccination consisted of an initial ocular spray vaccination on admission to the centre with live Lasota strain (Nobilis^®^ ND LASOTA, Kempton Park, South Africa) followed by an intramuscular injection of inactivated Lasota strain (Lomovac, TAD, Germany) (N.J. Parsons, unpublished data). There is no literature, to our knowledge that determines how long the vaccination antibodies remain detectable in a penguin following vaccination. Although it is unlikely that antibodies are still circulating 7 years after vaccination, it is possible that vaccination may have interfered with the results. SANCCOB stopped routinely marking all penguins before release into the wild in August 2005, but routinely vaccinated for NDV up until August 2008.

Mycoplasma spp. {#s20017}
---------------

Serological tests for MG and MS have not been routinely used in wild penguin species. There was inconsistency between the serological tests, with a higher frequency of positives when samples were tested with SPA compared to ELISA testing. While different subsets of samples were tested with each test, this discrepancy suggests an inherent difference in the sensitivity and specificity of the two tests. It is also important to consider that cross-reactivity with other *Mycoplasma* spp. from African penguins in this study is possible. Multiple *Mycoplasma* spp. (excluding MG and MS) have been demonstrated to occur in penguins (Banks, Cary & Hogg [@CIT0004]; Buckle *et al*. [@CIT0010]; Dewar *et al*. [@CIT0016]; Frasca *et al*. [@CIT0019]). Furthermore, Frasca *et al*. ([@CIT0019]) found cross-reactivity of antibodies against *Mycoplasma sphenisci* to antibodies against MG and MS in agglutination tests. Therefore, caution should be used when interpreting these results.

MG and MS potentially cause respiratory disease, sinusitis, conjunctivitis and synovitis in domestic and wild birds (Jordan [@CIT0035]). *Mycoplasma sphenisci* was described in an African penguin showing signs of upper respiratory tract disease in a North American aquarium (Frasca *et al*. [@CIT0019]) and *M. lipofaciens* was identified from the lungs of a Fiordland penguin (*Eudyptes pachyrhynchus*) after post-mortem examination showed bronchopneumonia (Buckle *et al*. [@CIT0010]). On the other hand, *M. sphenisci* and other *Mycoplasma* spp. have been detected in the faeces of apparently healthy penguins in Antarctica and subantarctic islands (Banks *et al*. [@CIT0004]; Dewar *et al*. [@CIT0016]). In this study, African penguins seropositive to MG in the SPA test had considerably lower serum concentrations of sodium, chloride and creatinine and higher concentrations of potassium, suggesting impairment of kidney function. Although MG and MS are known to produce renal lesions, these tend to be less prominent than respiratory and articular lesions (Jordan [@CIT0035]; Lockaby *et al*. [@CIT0042]). Future studies will be necessary to identify which species of *Mycoplasma* occurs in African penguins and to confirm if it produces significant renal disease.

It is worth noting that great white pelicans have been shown to have high prevalence (98%) of *Mycoplasma* spp. in South Africa (Assunção *et al*. [@CIT0003]). This species breeds sympatrically with and often predates on African penguins (Mwema, de Ponte Machado & Ryan [@CIT0045]). Furthermore, because great white pelicans are known to feed on avian offal in agricultural areas (Crawford, Cooper & Dyer [@CIT0011]), they could play a key role in spreading pathogens such as *Mycoplasma* spp. from domestic animals to seabirds (Assunção *et al*. [@CIT0003]).

Babesia sp. and Borrelia sp. {#s20018}
----------------------------

Although we did not fully characterise the blood parasites, their morphology was consistent with *Babesia peircei* and relapsing fever *Borrelia* as previously described in African penguins in the same region (Earlé *et al*. [@CIT0018]; Yabsley *et al*. [@CIT0068]). The apparent prevalence of *Babesia* sp. in wild African penguins in this study (1.5% -- 3.0%) is similar to that observed in previous studies, as is the higher frequency of *Babesia* sp. and *Borrelia* sp. among chicks and individuals undergoing rehabilitation (Brossy *et al*. [@CIT0009]; Earlé *et al*. [@CIT0018]; Yabsley *et al*. [@CIT0068]).

The pathological significance of *Babesia* sp. to penguins is not clear, and so far, this parasite has only been associated with only mild regenerative anaemia (Brossy *et al*. [@CIT0009]; Cunningham *et al*. [@CIT0015]; Vanstreels *et al*. [@CIT0062]). In this study, African penguin chicks with *Babesia* sp. had significantly different haematological and serum chemistry values compared to healthy chicks. *Babesia*-infected penguins had abnormalities in erythrocyte size and lower haemoglobin concentration, suggesting a regenerative response of the erythrocytic lineage, presumably to the haemolysis caused by the parasite. Higher white blood cell counts in *Babesia*-infected penguins indicate an active inflammatory response to the parasite and/or a stress response. Finally, higher serum levels of creatinine kinase and lower serum levels of uric acids and albumin indicate impairment of hepatic function and may also be partly related to haemolysis (see Harrison & Lightfoot [@CIT0030]).

Conclusion {#s0019}
==========

Considering the decreasing trend of the African penguin population (Crawford *et al*. [@CIT0013]), disease is yet another significant threat to the species in addition to poor nutrition, environmental degradation and anthropogenic impacts (Woods *et al*. [@CIT0065]). Serological surveillance can be a powerful tool to track the prevalence of pathogens that are otherwise difficult to detect in wildlife populations (Gilbert *et al*. [@CIT0024]). The reported seroprevalence in this study is consistent with previously reported studies on wild penguins, suggesting that these are endemic pathogens or natural, apathogenic flora. It must also be borne in mind that the presence of antibodies indicates past exposure to a pathogen and does not necessarily indicate presence of the organism or active infection. In addition, cross-reaction of tests with other antigens and microorganisms may interfere with specificity of the results (Barbosa & Palacios [@CIT0005]). Studies addressing the direct detection and isolation of pathogenic organisms in penguins are encouraged and, in combination with serological investigations, should provide deeper insight on their epidemiology in these birds.
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 {#s0022}

###### 

Details of sampling effort and serological results in relation to age group and sex.

  Group                       Age        Sex       Infectious bronchitis virus   Avian encephalomyelitis virus   Avian reovirus   AIV H5   AIV H7   Infectious bursal disease virus   Infectious laryngotracheitis virus   Newcastle disease virus   *Mycoplasma gallisepticum* (SPA)   *Mycoplasma gallisepticum* (ELISA)   *Mycoplasma synoviae* (SPA)   *Mycoplasma synoviae* (ELISA)   *Babesia* sp.   *Borrelia* sp.                                                     
  --------------------------- ---------- --------- ----------------------------- ------------------------------- ---------------- -------- -------- --------------------------------- ------------------------------------ ------------------------- ---------------------------------- ------------------------------------ ----------------------------- ------------------------------- --------------- ---------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Western Cape 2007--2008     Chick      Unknown   4                             \-                              4                \-       4        \-                                7                                    7                         4                                  \-                                   0                             7                               \-              7                \-   0    \-   7    1    0    \-   0    \-   0    \-
                              Juvenile   Unknown   1                             \-                              1                \-       1        \-                                0                                    0                         1                                  \-                                   0                             0                               \-              0                \-   0    \-   0    \-   0    \-   0    \-   0    \-
                              Adult      Unknown   102                           7                               102              1        102      3                                 91                                   91                        102                                5                                    0                             91                              2               88               5    0    \-   88   8    0    \-   0    \-   0    \-
  Namibia 2009                Adult      Male      10                            5                               10               1        10       1                                 9                                    9                         10                                 2                                    0                             9                               \-              9                \-   0    \-   9    \-   0    \-   19   \-   19   \-
                                         Female    10                            3                               10               1        10       \-                                11                                   11                        10                                 1                                    0                             11                              \-              11               \-   0    \-   11   \-   0    \-   21   1    21   \-
                                         Unknown   0                             \-                              0                \-       0        \-                                1                                    1                         0                                  \-                                   0                             1                               \-              1                \-   0    \-   1    \-   0    \-   1    \-   1    \-
  Western Cape 2010--2012     Adult      Male      53                            \-                              53               5        53       \-                                53                                   53                        53                                 2                                    23                            53                              1               28               5    20   1    32   \-   20   1    53   1    53   \-
                                         Female    47                            \-                              47               \-       47       \-                                47                                   47                        47                                 \-                                   14                            47                              2               25               7    20   \-   26   1    20   \-   47   2    47   \-
  Eastern Cape 2012           Adult      Male      26                            \-                              26               \-       26       \-                                26                                   26                        26                                 \-                                   0                             26                              \-              0                \-   26   \-   0    \-   26   \-   26   \-   26   \-
                                         Female    37                            \-                              37               \-       37       \-                                39                                   39                        37                                 \-                                   0                             39                              \-              0                \-   37   \-   0    \-   37   \-   39   1    39   \-
                                         Unknown   2                             \-                              2                \-       2        \-                                2                                    2                         2                                  \-                                   0                             2                               \-              0                \-   2    \-   0    \-   2    \-   1    \-   1    \-
  Rehabilitation 2010--2013   Chick      Male      24                            \-                              24               \-       24       \-                                25                                   25                        24                                 \-                                   19                            25                              \-              14               \-   10   \-   15   \-   10   \-   31   13   31   \-
                                         Female    18                            \-                              18               \-       18       \-                                16                                   16                        18                                 \-                                   17                            16                              \-              11               \-   4    \-   12   \-   4    \-   20   7    20   2
                                         Unknown   1                             \-                              1                1        1        \-                                1                                    1                         1                                  1                                    0                             1                               \-              0                \-   1    \-   0    \-   1    \-   1    1    1    \-
                              Juvenile   Male      14                            \-                              14               \-       14       \-                                14                                   14                        14                                 \-                                   0                             14                              \-              8                \-   6    \-   8    \-   6    \-   14   3    14   \-
                                         Female    10                            \-                              10               \-       10       \-                                11                                   11                        10                                 \-                                   0                             11                              \-              4                \-   7    \-   4    \-   7    \-   11   1    11   1
                              Adult      Male      41                            \-                              41               1        41       \-                                42                                   42                        41                                 1                                    0                             42                              \-              10               \-   31   \-   9    \-   31   \-   43   1    43   \-
                                         Female    39                            1                               39               3        39       \-                                40                                   40                        39                                 \-                                   0                             40                              \-              18               \-   21   \-   17   \-   21   \-   40   3    40   \-
                                         Unknown   4                             \-                              4                \-       4        \-                                4                                    4                         4                                  \-                                   0                             4                               \-              0                \-   4    \-   0    \-   4    \-   4    \-   4    \-

SPA, serum plate agglutination; ELISA, enzyme-linked immunosorbent assay.

###### 

Details of sampling effort and serological results in relation to sampling location and/or clinical history.

  Group                       Location or clinical history   Infectious bronchitis virus   Avian encephalomyelitis virus   Avian reovirus   AIV H5   AIV H7   Infectious bursal disease virus   Infectious laryngotracheitis virus   Newcastle disease virus   *Mycoplasma gallisepticum* (SPA)   *Mycoplasma gallisepticum* (ELISA)   *Mycoplasma synoviae* (SPA)   *Mycoplasma synoviae* (ELISA)   *Babesia* sp.   *Borrelia* sp.                                                     
  --------------------------- ------------------------------ ----------------------------- ------------------------------- ---------------- -------- -------- --------------------------------- ------------------------------------ ------------------------- ---------------------------------- ------------------------------------ ----------------------------- ------------------------------- --------------- ---------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Western Cape 2007--2008     Dassen Island                  41                            2                               41               \-       41       2                                 38                                   38                        41                                 1                                    0                             38                              1               37               2    0    \-   37   6    0    \-   0    \-   0    \-
                              Robben Island                  27                            5                               27               1        27       1                                 28                                   28                        27                                 1                                    0                             28                              \-              28               \-   0    \-   28   2    0    \-   0    \-   0    \-
                              Boulders                       0                             \-                              0                \-       0        \-                                10                                   10                        0                                  \-                                   0                             10                              1               9                \-   0    \-   9    \-   0    \-   0    \-   0    \-
  Namibia 2009                Dyer Island                    39                            \-                              39               \-       39       \-                                22                                   22                        39                                 3                                    0                             22                              \-              21               3    0    \-   21   1    0    \-   0    \-   0    \-
                              Halifax Island                 3                             \-                              3                \-       3        \-                                6                                    6                         3                                  \-                                   0                             6                               \-              6                \-   0    \-   6    \-   0    \-   9    \-   9    \-
                              Ichaboe Island                 8                             2                               8                1        8        1                                 4                                    4                         8                                  \-                                   0                             4                               \-              4                \-   0    \-   4    \-   0    \-   12   1    12   \-
                              Mercury Island                 7                             6                               7                1        7        \-                                8                                    8                         7                                  3                                    0                             8                               \-              8                \-   0    \-   8    \-   0    \-   15   \-   15   \-
                              Possession Island              2                             \-                              2                \-       2        \-                                3                                    3                         2                                  \-                                   0                             3                               \-              3                \-   0    \-   3    \-   0    \-   5    \-   5    \-
  Western Cape 2010--2012     Dassen Island                  20                            \-                              20               1        20       \-                                20                                   20                        20                                 \-                                   0                             20                              \-              0                \-   20   \-   0    \-   20   \-   20   1    20   \-
                              Robben Island                  20                            \-                              20               \-       20       \-                                20                                   20                        20                                 \-                                   0                             20                              \-              18               8    0    \-   20   \-   0    \-   20   1    20   \-
                              Boulders                       20                            \-                              20               4        20       \-                                20                                   20                        20                                 2                                    0                             20                              \-              0                \-   20   1    0    \-   20   1    20   \-   20   \-
                              Betty's Bay                    20                            \-                              20               \-       20       \-                                20                                   20                        20                                 \-                                   18                            20                              2               19               1    0    \-   20   \-   0    \-   20   \-   20   \-
                              Dyer Island                    20                            \-                              20               \-       20       \-                                20                                   20                        20                                 \-                                   19                            20                              1               16               3    0    \-   18   1    0    \-   20   1    20   \-
  Eastern Cape 2012           Bird Island                    48                            \-                              48               \-       48       \-                                50                                   50                        48                                 \-                                   0                             50                              \-              0                \-   48   \-   0    \-   48   \-   50   1    50   \-
                              St. Croix Island               17                            \-                              17               \-       17       \-                                17                                   17                        17                                 \-                                   0                             17                              \-              0                \-   17   \-   0    \-   17   \-   16   21   16   \-
  Rehabilitation 2010--2013   Oiled                          59                            1                               59               3        59       \-                                59                                   59                        59                                 1                                    0                             59                              \-              29               2    26   \-   29   \-   29   \-   60   1    60   \-
                              Chick                          43                            \-                              43               1        43       \-                                42                                   42                        43                                 1                                    36                            42                              \-              15               \-   27   \-   15   \-   15   \-   52   \-   52   2
                              Moulting                       16                            \-                              16               \-       16       \-                                17                                   17                        16                                 \-                                   0                             17                              \-              14               \-   3    \-   14   \-   14   \-   17   3    17   \-
                              Weak/wounded                   33                            \-                              33               1        33       \-                                35                                   35                        33                                 \-                                   0                             35                              \-              26               \-   9    \-   26   \-   26   \-   35   4    35   1

SPA, serum plate agglutination; ELISA, enzyme-linked immunosorbent assay.
